Eton Pharmaceuticals Inc (ETON)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Eton Pharmaceuticals Inc

Healthcare (1152)

(847) 787-7361

21925 W. FIELD PARKWAY, DEER PARK, IL

최신 SEC 제출 서류

ETON's Discussions on Twitter

ETON을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ETON Eton Pharmaceuticals Inc	13.96	367.94M	31.38M	-6.69M	-1.84M	-0.26
ZTS Zoetis Inc	145.49	67.28B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.12	45.61B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.82	45.01B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	13.28	15.64B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	283.04	12.77B	2.76B	1.11B	898.10M	22.77

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-01-23	재확인	H.C. Wainwright	Buy
2025-01-10	개시	B. Riley Securities	Buy
2025-01-06	재확인	H.C. Wainwright	Buy
2024-09-04	재개	H.C. Wainwright	Buy
2024-05-06	개시	Craig Hallum	Buy
2021-10-14	재개	B. Riley Securities	Buy
2021-01-04	재확인	H.C. Wainwright	Buy
2019-09-20	개시	B. Riley FBR	Buy
2019-06-10	개시	H.C. Wainwright	Buy

Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스

Eton Pharmaceuticals Inc (ETON) 재무 분석

Eton Pharmaceuticals Inc (ETON)

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

ETON을(를) 다른 주식과 비교

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Increase in Short Interest - Defense World

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability - Yahoo Finance

Raymond James Financial Inc. Makes New Investment in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

Retail investors who have a significant stake must be disappointed along with institutions after Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) market cap dropped by US$35m - simplywall.st

(ETON) Technical Data - news.stocktradersdaily.com

Eton sells ex-U.S. rights for hormone disorder therapy to Esteve Pharma - MSN

Eton sells overseas rights for hormone disorder drug (ETON) - Seeking Alpha

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals - MarketScreener

Eton Pharma Out-Licenses International Rights To Increlex To Esteve Pharma - Nasdaq

Eton Pharmaceuticals out-licenses international rights to Increlex - TipRanks

Eton Pharmaceuticals IncEsteve To Pay Eur4 Million Up Front For Increlex RightsSEC Filing - MarketScreener

Eton Pharmaceuticals licenses Increlex rights abroad - Investing.com

Eton Pharmaceuticals licenses Increlex rights abroad By Investing.com - Investing.com UK

Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewswire

Major Pharma Deal: Eton's Smart Move Unlocks Global Market for Rare Disease Treatment - Stock Titan

Eton Pharmaceuticals Inc (ETON) Shares Down 4.87% on Mar 25 - GuruFocus

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program - The Manila Times

REG-CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program - TradingView

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency… - Informazione.it

Research Analysts Set Expectations for ETON Q2 Earnings - Defense World

Q3 EPS Estimates for Eton Pharmaceuticals Lifted by B. Riley - Defense World

Eton Pharmaceuticals’ (ETON) “Buy” Rating Reiterated at HC Wainwright - Defense World

Eton Pharmaceuticals Inc (ETON) Stock Price Down 3.79% on Mar 22 - GuruFocus

B. Riley Reiterates Buy Rating for Eton Pharmaceuticals (NASDAQ:ETON) - Defense World

Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, Craig Hallum Analyst Says - Defense World

Q1 EPS Forecast for Eton Pharmaceuticals Boosted by Analyst - Defense World

5 Analysts Assess Eton Pharmaceuticals: What You Need To Know - Benzinga

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Call Transcript - Insider Monkey

B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating - MarketScreener

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo

Eton Pharmaceuticals Reports Record Q4 Revenue Growth - TipRanks

Eton Pharmaceuticals Reports Strong Growth and Strategic Acquisitions - TipRanks

Eton Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - TradingView

Eton Pharmaceuticals Reports Record Q4 2024 Revenue and Successful Product Launches Ahead of Investor Day Conference Call - Nasdaq

Eton Pharmaceuticals Achieves 16th Straight Quarter of Growth, Doubles Product Portfolio - StockTitan

Earnings Scheduled For March 18, 2025 - Benzinga

Eton Pharmaceuticals (NASDAQ:ETON) shareholder returns have been incredible, earning 421% in 5 years - Simply Wall St

(ETON) On The My Stocks Page - news.stocktradersdaily.com

Eton Pharmaceuticals nears NDA submission for new drug By Investing.com - Investing.com Australia

Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch - Benzinga India

Eton Pharma rises on study results for rare disease drug - TradingView

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Eton's Diabetes Drug Candidate Passes Bioequivalence Study -March 14, 2025 at 07:21 am EDT - Marketscreener.com

Eton Pharmaceuticals nears NDA submission for new drug - Investing.com India

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - Eagle-Tribune

Breakthrough for Pediatric Diabetes: Eton's Liquid Desmopressin Aces Pivotal Trial - StockTitan

Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Eton Pharmaceuticals (ETON) to Release Earnings on Thursday - Defense World

Eton Pharmaceuticals Inc (ETON) 재무 분석

매출

순이익

현금흐름

주당 순 이익

ETON과 유사한 종목